BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37084468)

  • 1. Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer.
    Zhou J; Luo L; Xie L; Hu S; Tan L; Lei X; Luo X; Yang M
    Clin Nutr; 2023 Jun; 42(6):817-824. PubMed ID: 37084468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery.
    Vieira FT; Godziuk K; Lamarca F; Melendez-Araújo MS; Lima RM; Prado CM; de Carvalho KMB; Dutra ES
    Clin Nutr; 2022 Sep; 41(9):1932-1941. PubMed ID: 35947895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study.
    Huang S; Li J; Chen M; Zhu T; Lei X; Li Q; Yang Q; Chen X
    Clin Nutr ESPEN; 2024 Apr; 60():343-347. PubMed ID: 38479933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.
    Scott D; Blyth F; Naganathan V; Le Couteur DG; Handelsman DJ; Waite LM; Hirani V
    Clin Nutr; 2023 Sep; 42(9):1610-1618. PubMed ID: 37481869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation.
    Shimizu A; Maeda K; Ueshima J; Inoue T; Murotani K; Ohno T; Nomoto A; Nagano A; Kayashita J; Mori N; Fujishima I
    Mech Ageing Dev; 2022 Dec; 208():111728. PubMed ID: 36084796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of sarcopenic obesity according to different diagnostic methods and cut-off points in candidates for bariatric surgery.
    González Arnáiz E; Ariadel Cobo D; Estébanez B; Barajas Galindo D; Pintor de la Maza B; Urioste Fondo A; Dameto Pons C; Cuevas MJ; Ballesteros Pomar MD
    Clin Nutr; 2024 May; 43(5):1087-1093. PubMed ID: 38579371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neck circumference as a potential indicator of pre-sarcopenic obesity in a cohort of community-based individuals.
    Xu Y; Li X; Hu T; Shen Y; Xiao Y; Wang Y; Bao Y; Ma X
    Clin Nutr; 2024 Jan; 43(1):11-17. PubMed ID: 37992633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.
    Donini LM; Busetto L; Bischoff SC; Cederholm T; Ballesteros-Pomar MD; Batsis JA; Bauer JM; Boirie Y; Cruz-Jentoft AJ; Dicker D; Frara S; Frühbeck G; Genton L; Gepner Y; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Nyulasi I; Parrinello E; Poggiogalle E; Prado CM; Salvador J; Rolland Y; Santini F; Serlie MJ; Shi H; Sieber CC; Siervo M; Vettor R; Villareal DT; Volkert D; Yu J; Zamboni M; Barazzoni R
    Clin Nutr; 2022 Apr; 41(4):990-1000. PubMed ID: 35227529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of the Diagnostic Criteria for Sarcopenic Obesity Defined by ESPEN/EASO Criteria in Acutely Admitted Patients with Stroke: Prevalence and Association with Outcomes.
    Abe T; Yoshimura Y; Sato Y; Nagano F; Matsumoto A
    J Nutr Sci Vitaminol (Tokyo); 2023; 69(6):454-462. PubMed ID: 38171818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.
    Donini LM; Busetto L; Bischoff SC; Cederholm T; Ballesteros-Pomar MD; Batsis JA; Bauer JM; Boirie Y; Cruz-Jentoft AJ; Dicker D; Frara S; Frühbeck G; Genton L; Gepner Y; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Nyulasi I; Parrinello E; Poggiogalle E; Prado CM; Salvador J; Rolland Y; Santini F; Serlie MJ; Shi H; Sieber CC; Siervo M; Vettor R; Villareal DT; Volkert D; Yu J; Zamboni M; Barazzoni R
    Obes Facts; 2022; 15(3):321-335. PubMed ID: 35196654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Applicability of the ESPEN and EASO-Defined Diagnostic Criteria for Sarcopenic Obesity in Japanese Patients after Stroke: Prevalence and Association with Outcomes.
    Yoshimura Y; Wakabayashi H; Nagano F; Matsumoto A; Shimazu S; Shiraishi A; Kido Y; Bise T
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence and Agreement of Sarcopenic Obesity Using Different Definitions and Its Association with Mild Cognitive Impairment.
    Fu Y; Li X; Wang T; Yan S; Zhang X; Hu G; Zhou J; Wang Y; Liu C; Wang S; Cong Y; Chen L; Li T; Rong S
    J Alzheimers Dis; 2023; 94(1):137-146. PubMed ID: 37212103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and diagnostic agreement of sarcopenic obesity with different definitions among Chinese community-dwelling older adults.
    Mo YH; Yang C; Su YD; Dong X; Deng WY; Liu BB; Yao XM; Wang XH
    Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.
    Donini LM; Busetto L; Bauer JM; Bischoff S; Boirie Y; Cederholm T; Cruz-Jentoft AJ; Dicker D; Frühbeck G; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Parrinello E; Poggiogalle E; Prado CM; Rodriguez JS; Rolland Y; Santini F; Siervo M; Tecilazich F; Vettor R; Yu J; Zamboni M; Barazzoni R
    Clin Nutr; 2020 Aug; 39(8):2368-2388. PubMed ID: 31813698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.
    Tang T; Xie L; Hu S; Tan L; Lei X; Luo X; Yang L; Yang M
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1800-1810. PubMed ID: 35297568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenic Obesity: Time to Meet the Challenge.
    Barazzoni R; Bischoff S; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
    Obes Facts; 2018; 11(4):294-305. PubMed ID: 30016792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.
    Atlan P; Bayar MA; Lanoy E; Besse B; Planchard D; Ramon J; Raynard B; Antoun S
    Support Care Cancer; 2017 Nov; 25(11):3365-3373. PubMed ID: 28593463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of high body mass index, waist circumference, and body fat percentage with sarcopenia in older women.
    Yoo MC; Won CW; Soh Y
    BMC Geriatr; 2022 Dec; 22(1):937. PubMed ID: 36471279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenic obesity is not associated with sexual dysfunction in older adults: a cross-sectional study.
    Demirdağ F; Kıvrak Güçer B; Kolbaşı EN
    Aging Male; 2023 Dec; 26(1):2252502. PubMed ID: 37905446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of EASO/ESPEN-Defined Sarcopenic Obesity Following a Technology-Based Weight Loss Intervention.
    Wood BS; Batchek DJ; Lynch DH; Spangler HB; Gross DC; Petersen CL; Batsis JA
    Calcif Tissue Int; 2024 Jan; 114(1):60-73. PubMed ID: 37758867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.